Curocell Inc. (KOSDAQ:372320)

South Korea · Delayed Price · Currency is KRW

25,100

+400 (1.62%)

At close: Aug 20, 2026

Curocell Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Gross Profit	-17.43	-19.6	-10.49	-14.19
Operating Income	-37,846	-36,290	-36,624	-31,130
Net Income	-48,202	-46,305	-38,239	-29,575
Earnings Per Share	-3336.88	-3232.17	-2736.00	-2499.18
EPS Growth	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Investments	16,196	24,165	11,781	41,917
Total Debt	48,188	56,681	37,300	42,918
Net Cash (Debt)	-31,992	-32,516	-25,519	-1,000
Net Cash Growth	-	-	-	-
Net Cash Per Share	-2214.71	-2269.66	-1825.90	-84.54

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	-31,984	-29,993	-28,532	-25,264
Capital Expenditures	-363.39	-313.23	-441.02	-21,164
Free Cash Flow	-32,348	-30,306	-28,973	-46,428
Free Cash Flow Growth	-	-	-	-

Valuation

Selected indicators aren't available for this stock.